Form 4: Disc Medicine Executive Sells Shares to Cover Tax Obligations

Pamela Stephenson, Chief Commercial Officer of Disc Medicine, Inc., sold shares to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On February 18, 2025, Pamela Stephenson, the Chief Commercial Officer of Disc Medicine, Inc. (IRON), sold 3,137 shares of common stock at a price of $54.58 per share.
• The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units granted on February 26, 2024.
• Following the transaction, Stephenson directly owns 69,529 shares of Disc Medicine, Inc.

Sentiment

Score: 6

Explanation: The document describes a routine transaction (sell to cover taxes) and doesn't inherently indicate positive or negative sentiment about the company's prospects. It's a neutral event.

Management Comments

• The sale is a 'sell to cover' transaction and does not represent a discretionary transaction by the Reporting Person.

Industry Context

Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives and do not necessarily indicate a negative outlook on the company's future.

Comparison to Industry Standards

• Executive compensation packages often include restricted stock units that vest over time.
• Upon vesting, these units are subject to income tax, and executives commonly sell a portion of the shares to cover these tax liabilities.
• This practice is widespread across various industries and companies, including those comparable to Disc Medicine in the biotechnology sector.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine sale to cover tax obligations.

Key Dates

Keywords

Form 4, Disc Medicine, IRON, Pamela Stephenson, Chief Commercial Officer, Stock Sale, Tax Withholding, Restricted Stock Units, Beneficial Ownership